Miller, J.M.

stroke patient nonhemorrhagic stroke nonhemorrhagic infarction trial syndrome heart rate pursuit ischemic attack baseline heart predictor therapy incidence study eptifibatide population 30- day follow-up history patient population st-segment elevation hemorrhagic stroke rates factor diabetes mellitus 10 948 patients hemorrhagic conversion pursuit trial glycoprotein intracranial hemorrhage risk factors ischemic table receptor st-segment angina result /iiia elevation treatment receptor suppression diabetes attack gusto thrombolytic therapy deficit integrilin therapy 30 days group circulation intracranial thrombolytic placebo mellitu outcome hemorrhage model onset mahaffey event investigator baseline predictors hospital discharge nomogram blood aspirin enrollment hospital thrombolysi heparin platelet committee brain imaging high-dose eptifibatide julie m conversion follow-up stroke types stroke adjudication committee